Zydus Lifesciences Limited Press Release Aug 11 2026

About this update from Zydus Lifesciences Limited

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 11, 2026, titled "Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency- Associated Lung Disease (AATD-LD)". View Attachment

View stock analysis, news, and events for Zydus Lifesciences Limited